Nextech Invest Ag Tango Therapeutics, Inc. Transaction History
Nextech Invest Ag
- $613 Million
- Q3 2024
A detailed history of Nextech Invest Ag transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Nextech Invest Ag holds 5,533,980 shares of TNGX stock, worth $21.3 Million. This represents 6.95% of its overall portfolio holdings.
Number of Shares
5,533,980
Previous 5,533,980
-0.0%
Holding current value
$21.3 Million
Previous $47.5 Million
10.26%
% of portfolio
6.95%
Previous 8.96%
Shares
1 transactions
Others Institutions Holding TNGX
# of Institutions
123Shares Held
91.7MCall Options Held
3.1KPut Options Held
1.5K-
Trv Gp Iv, LLC Boston, MA16.9MShares$64.9 Million80.09% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA13.3MShares$51.3 Million4.45% of portfolio
-
Boxer Capital, LLC San Diego, CA8.2MShares$31.6 Million3.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.02MShares$19.3 Million0.02% of portfolio
-
Southpoint Capital Advisors LP New York, NY5MShares$19.3 Million1.08% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $339M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...